activated clotting time

Original Contribution

Activated Clotting Time and Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS-CTO Registry

12/05/2023

Bahadir Simsek, MD¹; Athanasios Rempakos, MD¹; Spyridon Kostantinis, MD¹; Michaella Alexandrou, MD¹; Sevket Gorgulu, MD²; Khaldoon Alaswad, MD³; Jarrod D. Frizzell, MD⁴; Ufuk Yildirim, MD⁵; Paul Poommipanit, MD⁶; Nazif Aygul, MD⁷; Nidal Abi Rafeh, MD⁸, Rodrigo Bagur, MD, PhD⁹; Rhian Davies, MD¹⁰; Omer Goktekin, MD¹¹; James W. Choi, MD¹²; Niranjan Reddy, MD¹³; Philip Dattilo, MD¹⁴; Jimmy Kerrigan, MD¹⁵; Elias V. Haddad, MD¹⁵; Olga C. Mastrodemos, BA¹; Bavana V. Rangan, BDS, MPH¹; Judit Karacsonyi, MD, PhD¹; Salman S. Allana, MD¹; Kathleen E. Kearney, MD¹⁶; Yader Sandoval, MD¹; M. Nicholas Burke, MD¹; Emmanouil S. Brilakis, MD, PhD¹; Lorenzo Azzalini, MD, PhD, MSc¹⁶

Bahadir Simsek, MD1; Athanasios Rempa...

The authors evaluated the association between activated clotting time and in-hospital clinical outcomes in a large international multicenter chronic total occlusion-percutaneous coronary intervention registry.

The authors evaluated the...

12/05/2023

Journal of Invasive Cardiology